Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency
admin Prasad’s tenure has been nothing short of transformative, albeit deeply divisive. As the head of...
Health
Artis BioSolutions Taps Vaccine Veteran Kate Broderick to Lead Scientific Innovation as Biotech Talent War Intensifies
The executive revolving door in the biotechnology sector continues to spin at a dizzying pace,...
Faith, Freedom, and the Needle: The Supreme Court’s High-Stakes Review of Amish Vaccine Mandates in New York.
The legal battle over religious liberty and public health has reached a pivotal juncture as...
Breaching the IBD efficacy ceiling, and sham surgeries
The quest to shatter this ceiling is currently the most competitive frontier in immunology. Leading...
RFK Jr. Targets Sugar in Major Food Safety Overhaul, Challenging Dunkin’ and Starbucks to Prove Beverage Safety.
In a move that signals a seismic shift in the federal government’s approach to nutrition...
Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind mRNA vaccines
Under the terms of the agreement, Roivant will receive an immediate cash payment of $950...
The Democratization of Negligence: How Telehealth Ketamine Companies Abandon Patients in Their Most Vulnerable Moments.
Telehealth companies are currently mailing Schedule III narcotics to tens of thousands of depressed patients...
Kansas’ new ID law could have health consequences for trans people
The most visible shift in federal health communication is currently embodied by Robert F. Kennedy...
SEC Filings Reveal Hidden Details of Trump’s Most-Favored Nation Drug Pricing Agreements with Pharmaceutical Giants.
For years, the intersection of pharmaceutical pricing and federal policy has been a battlefield of...
Minnesota report shows large hospitals continue to dominate the 340B drug discount program
The 340B program, created by Congress in 1992, was originally designed to stretch scarce federal...